Brian Riley
About Brian Riley
Brian Riley is a seasoned manufacturing executive with extensive experience in the biotechnology and pharmaceutical industries.
Chief Manufacturing Officer at Catalent Pharma Solutions
Brian Riley serves as the Chief Manufacturing Officer at Catalent Pharma Solutions. In his current role, he oversees all manufacturing operations within the company. His extensive experience in biologics and operations provides a solid foundation for optimizing manufacturing processes and ensuring compliance with stringent industry standards.
Educational Background of Brian Riley
Brian Riley earned his MBA from Campbell University, equipping him with advanced skills in business management and strategic planning. He also holds a Bachelor of Science degree from North Carolina State University, laying a technical foundation in relevant scientific disciplines. This combination of education allows him to bring both managerial and technical perspectives to his roles.
Professional Experience at Catalent Pharma Solutions
During his five-year tenure at Catalent Pharma Solutions, Brian Riley held several key positions, including General Manager of Biologics and Vice President of Operations. These roles involved overseeing large-scale biologic manufacturing operations, managing cross-functional teams, and driving process improvements to enhance operational efficiency.
Role as Site Director at bioMerieux
Brian Riley served as the Site Director for Durham, NC operations at bioMerieux. In this capacity, he was responsible for managing the overall site operations, ensuring production targets were met, and maintaining high standards of quality and safety in the manufacturing processes.
Career in Quality and Operations at Biogen Idec, Amgen, and Diosynth Biotechnology
Brian Riley has also held various roles in quality and operations at renowned firms such as Biogen Idec, Amgen, and Diosynth Biotechnology. His work at these companies involved implementing quality management systems, driving operational excellence, and ensuring regulatory compliance in pharmaceutical manufacturing environments.